Take the best Irish experience, commitment and creative resources to facilitate drug and device development, and add some Finnish world-class know-how in clinical research – here you have Venn Life Sciences Limited. The life science sector now has a new strong player in the capital regions of Ireland and Finland, as Dublin-based Venn Life Sciences Holdings Limited and Espoo-based Encorium Group combined forces to create this company.
Venn Life Sciences Holdings Limited is a leading provider of development consulting and resourcing services to the pharmaceutical, biotechnology and medical devices industries and Encorium Group is a full service contract research organisation (CRO), offering clinical research framework for conducting clinical trials. The combined business will have over 200 employees, operating from over 20 locations worldwide.
A good day for both companies
Joining forces created benefits for both parties of the new company.
– This is a good day for both companies. Our combined management, operational and project teams have many years of clinical and consulting experience in the various forms of clinical development models. This variation of experience will be a critical component to future success in the clinical outsourcing arena, said Tony Richardson, Executive Chairman of Venn, in a press release.
– Having spent considerable time evaluating strategic alternatives, in order to bring long-term stability for all Encorium stakeholders, I am very pleased with today’s announcement. In particular, I am pleased that the months of planning have yielded a successful outcome and one that will ensure continuity of business for our clients and employees, said Kai Lindevall, Encoriums’s CEO.
